CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 108 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,308,097 | +631.5% | 1,026,700 | +327.8% | 0.24% | +490.0% |
| Q1 2023 | $2,092,800 | +75.7% | 240,000 | +26.3% | 0.04% | +122.2% |
| Q4 2022 | $1,191,300 | +242.3% | 190,000 | +90.0% | 0.02% | +350.0% |
| Q3 2022 | $348,000 | -15.5% | 100,000 | -28.6% | 0.00% | -20.0% |
| Q2 2022 | $412,000 | +9.9% | 140,000 | +16.7% | 0.01% | +25.0% |
| Q1 2022 | $375,000 | -40.4% | 120,000 | -33.3% | 0.00% | -80.0% |
| Q2 2020 | $629,000 | +192.6% | 179,900 | +499.7% | 0.02% | +81.8% |
| Q2 2019 | $215,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |